Home

Edward M. Cox

CIK 1478732 · VP of Business Development · last filed 2014-02-24

Edward M. Cox is a VP of Business Development who has filed 12 SEC Form 4 insider transactions across 2 companies since 2010. The most recent filing, for APRI, was dated Feb 24, 2014. Across all open-market trades the lifetime net is +$4.1K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $86.9K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$86.9K

Companies

2

Total Filings

12

Lifetime Open-Market Net

$4.1K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SEELOS THERAPEUTICS, INC. (APRI) Delisted VP of Business Development 5,285 — — $4.1K 7 2014-02-24
NEXM VP of Corp. Development 36,826 $2.36 $86.9K $0 3 2010-04-13

Recent Filings

12 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2014-02-24 SEELOS THERAPEUTICS, INC. (APRI) Delisted Grant (A) — $0 EDGAR
2014-02-10 SEELOS THERAPEUTICS, INC. (APRI) Delisted Grant (A) — $0 EDGAR
2012-12-20 SEELOS THERAPEUTICS, INC. (APRI) Delisted Grant (A) — $0 EDGAR
2012-08-22 SEELOS THERAPEUTICS, INC. (APRI) Delisted Buy (P) +1,500 $4.1K EDGAR
2012-03-28 SEELOS THERAPEUTICS, INC. (APRI) Delisted Other (J) +13,574 $0 EDGAR
2012-03-07 SEELOS THERAPEUTICS, INC. (APRI) Delisted Grant (A) — $0 EDGAR
2011-05-19 SEELOS THERAPEUTICS, INC. (APRI) Delisted Mixed +29,111 $0 EDGAR
2010-07-16 — Grant (A) +60,935 $0
2010-06-25 — Grant (A) +52,594 $132.5K
2010-04-13 NEXM Grant (A) +75,000 $0 EDGAR
Showing 1–10 of 12
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.